These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 34843666)

  • 41. Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital.
    Tiseo G; Galfo V; Occhineri S; Forniti A; Caroselli C; Falcone M; Menichetti F
    Infez Med; 2022; 31(1):55-61. PubMed ID: 36908395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
    Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
    Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics.
    van Grootveld R; van Paassen J; Claas ECJ; Heerdink L; Kuijper EJ; de Boer MGJ; van der Beek MT;
    Med Mycol; 2024 May; 62(5):. PubMed ID: 38544330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study.
    Massart N; Reizine F; Dupin C; Legay F; Legris E; Cady A; Rieul G; Barbarot N; Magahlaes E; Fillatre P
    Infect Dis (Lond); 2023 Apr; 55(4):263-271. PubMed ID: 36694427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cumulative steroid dose in hospitalized patients and COVID-19-associated pulmonary aspergillosis.
    Ramonfaur D; Salto-Quintana JN; Aguirre-García GM; Hernández-Mata NM; Villanueva-Lozano H; Torre-Amione G; Martínez-Reséndez MF
    J Hosp Infect; 2023 Dec; 142():26-31. PubMed ID: 37499762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data.
    Casalini G; Giacomelli A; Galimberti L; Colombo R; Ballone E; Pozza G; Zacheo M; Galimberti M; Oreni L; Carsana L; Longo M; Gismondo MR; Tonello C; Nebuloni M; Antinori S
    J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
    Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
    J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
    Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients.
    Torres A; Motos A; Riera J; Fernández-Barat L; Ceccato A; Pérez-Arnal R; García-Gasulla D; Peñuelas O; Lorente JA; Rodriguez A; de Gonzalo-Calvo D; Almansa R; Gabarrús A; Menéndez R; Bermejo-Martin JF; Ferrer R; Amaya Villar R; Añón JM; Barberà C; Barberán J; Blandino Ortiz A; Bustamante-Munguira E; Caballero J; Carbajales C; Carbonell N; Catalán-González M; Galbán C; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego E; García Garmendia JL; Garnacho-Montero J; Gómez JM; Huerta A; Jorge García RN; Loza-Vázquez A; Marin-Corral J; Martínez de la Gándara A; Martínez Varela I; López Messa J; M Albaiceta G; Novo MA; Peñasco Y; Pozo-Laderas JC; Ricart P; Salvador-Adell I; Sánchez-Miralles A; Sancho Chinesta S; Socias L; Solé-Violan J; Suares Sipmann F; Tamayo Lomas L; Trenado J; Barbé F;
    Crit Care; 2021 Sep; 25(1):331. PubMed ID: 34517881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
    Nasir N; Farooqi J; Mahmood SF; Jabeen K
    Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for ventilator-associated lower respiratory tract infection in COVID-19, a retrospective multicenter cohort study in Sweden.
    Forsberg G; Taxbro K; Elander L; Hanberger H; Berg S; Idh J; Berkius J; Ekman A; Hammarskjöld F; Niward K; Balkhed ÅÖ
    Acta Anaesthesiol Scand; 2024 Feb; 68(2):226-235. PubMed ID: 37751991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant.
    Wang Y; Yao Y; Zhang Q; Chen H; He Y; Hu K
    BMC Infect Dis; 2024 Jan; 24(1):117. PubMed ID: 38263011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Mitaka H; Kuno T; Takagi H; Patrawalla P
    Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
    Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
    Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.
    Leistner R; Schroeter L; Adam T; Poddubnyy D; Stegemann M; Siegmund B; Maechler F; Geffers C; Schwab F; Gastmeier P; Treskatsch S; Angermair S; Schneider T
    Crit Care; 2022 Jan; 26(1):30. PubMed ID: 35090528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.